Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Er-Cheng, Chen"'
Autor:
Yi-Peng, Song, Jin-Bo, Ma, Lin, Wang, Er-Cheng, Chen, Peng, Liu, Zhao, Ma, Ru-Kun, Zang, Jin-Ming, Yu
Publikováno v:
Asia-Pacific journal of clinical oncology. 13(2)
To evaluate the efficacy and safety of late-course hypofractionated radiation treatment of muscle-invasive bladder carcinoma after bladder-conserving surgery.Seventy-six patients with transitional cell bladder carcinoma, stage II (T2-4N0M0), after tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::68c07e40ae82e7fa2b31833fa015888d
https://pubmed.ncbi.nlm.nih.gov/25869382
https://pubmed.ncbi.nlm.nih.gov/25869382
Publikováno v:
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi. 32(12)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4cdd5c57a57a79ee4da518d4fa3b7fb0
https://pubmed.ncbi.nlm.nih.gov/22339974
https://pubmed.ncbi.nlm.nih.gov/22339974
Autor:
Er-Cheng, Chen, Meng-Zhong, Liu, Yong-Hong, Hu, Qiao-Qiao, Li, Hui, Liu, Ling, Cai, Huan-Xin, Lin, Ying, Huang, Han-Yu, Wang, Nian-Ji, Cui
Publikováno v:
Ai zheng = Aizheng = Chinese journal of cancer. 24(6)
Concurrent chemoradiotherapy is recommended as standard treatment for unresectable esophageal carcinoma now. This study was to analyze the prognostic factors of unresectable esophageal carcinoma after concurrent chemoradiotherapy.A total of 132 unres
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e7871d46adfaf8dbd87bfbbf09b00008
https://pubmed.ncbi.nlm.nih.gov/15946490
https://pubmed.ncbi.nlm.nih.gov/15946490
Publikováno v:
Zhonghua zhong liu za zhi [Chinese journal of oncology]. 27(2)
To analyze treatment and prognostic factors of 74 patients with dermatofibro-sarcoma protuberans (DFSP).From August 1990 to November 1999, 74 patients with DFSP confirmed pathologically were treated. There were 52 males and 22 females with a median a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4781eb0c3a53818628012009c34df0cd
https://pubmed.ncbi.nlm.nih.gov/15946556
https://pubmed.ncbi.nlm.nih.gov/15946556
Autor:
Ling, Cai, Meng-Zhong, Liu, Mo-Fa, Gu, Hui, Liu, Er-Cheng, Chen, Yong-Hong, Hu, Huan-Xin, Lin, Han-Yu, Wang, Ying, Huang, Qiao-Qiao, Li, Nian-Ji, Cui, Tie-Hua, Rong
Publikováno v:
Ai zheng = Aizheng = Chinese journal of cancer. 24(5)
Although concurrent radiochemotherapy is recommended as the standard treatment for advanced esophageal carcinoma, the local failure still reaches up to 44%-54%. This study aimed to explore maximum tolerance dose (MTD) of sodium glycididazole(CM-Na) i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e9fe598f6651f1ccd03715e65c6a30de
https://pubmed.ncbi.nlm.nih.gov/15890102
https://pubmed.ncbi.nlm.nih.gov/15890102
Autor:
Er-Cheng, Chen, Meng-Zhong, Liu, Yong-Hong, Hu, Hui, Liu, Qiao-Qiao, Li, Ling, Cai, Ying, Huang, Huan-Xin, Lin, Han-Yu, Wang, Nian-Ji, Cui
Publikováno v:
Ai zheng = Aizheng = Chinese journal of cancer. 24(4)
Concurrent chemoradiotherapy is the standard treatment for unresectable esophageal carcinoma. Local failure and recurrence are main reasons of treatment failure. This study was to discuss the factors related with local failure and recurrence of unres
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5efd5d5fd19dff52ee023109f28936d5
https://pubmed.ncbi.nlm.nih.gov/15820078
https://pubmed.ncbi.nlm.nih.gov/15820078
Autor:
Song, Yi‐peng1,2, Ma, Jin‐bo2, Wang, Lin3, Chen, Er‐cheng2, Liu, Peng2, Ma, Zhao2, Zang, Ru‐kun2, Yu, Jin‐ming4 sdyujinming@126.com
Publikováno v:
Asia Pacific Journal of Clinical Oncology. Apr2017, Vol. 13 Issue 2, pe111-e116. 6p.